logo

For the Inventor, By the Inventor

Hiller.o slashed.d, Denmark

Birgitte Hjort Guldhammer

This inventor holds 9 USPTO granted patents. Top assignee: Novo Nordisk A/s. Active years: 1997-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Birgitte Hjort Guldhammer. Retrieved from https://idiyas.com/inventor/birgitte-hjort-guldhammer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 114(Granted Patents)


Company Filing History:

goldMedal9 out of 1,802 
 
Novo Nordisk A/s
 patents

Years Active: 1997-1999

Loading Chart...
9 patents (USPTO):Explore Patents
1. 6008242 - Use of 1-centchroman for the manufacture of a pharmaceutical composition (1999-12-28),
2. 5919812 - Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical (1999-07-06),
3. 5886021 - Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical (1999-03-23),
4. 5883118 - Prostatic carcinoma (1999-03-16),
5. 5827873 - Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical (1998-10-27),
6. 5780502 - Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical (1998-07-14),
7. 5756539 - 3, 4-diphenyl chromans for inhibiting one or more psychiatric disorders (1998-05-26),
8. 5726202 - Benign prostatic hypertrophy (1998-03-10),
9. 5696149 - Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical (1997-12-09),

Title: Birgitte Hjort Guldhammer: Pioneering Innovations in Pharmaceutical Treatments

Introduction:

Birgitte Hjort Guldhammer is a visionary inventor based in Hillerød, Denmark, with a stellar reputation for transforming groundbreaking ideas into tangible solutions. His relentless dedication to advancing technology and driving positive change exemplifies his status as a true trailblazer in the realm of inventions and innovations.

Latest Patents:

Guldhammer's latest patents showcase his ingenuity and commitment to revolutionizing the field of pharmaceutical treatments. With inventions like the use of 1-centchroman for obesity treatment and 3,4-diphenyl chromans for gynaecomastia, he continues to push the boundaries of medical science.

Career Highlights:

During his illustrious career, Guldhammer has made significant contributions to renowned companies such as Novo Nordisk A/S, where he has played a pivotal role in developing cutting-edge treatments and therapies. His expertise and innovative approaches have earned him recognition as a key figure in the pharmaceutical industry.

Collaborations:

Guldhammer's collaborative spirit is evident through his partnerships with esteemed colleagues such as Niels Korsgaard and Michael Shalmi. Together, they have synergized their talents to drive forward groundbreaking projects and achieve remarkable breakthroughs in the field of healthcare innovation.

Conclusion:

In conclusion, Birgitte Hjort Guldhammer's unwavering passion for creating a brighter future through inventive solutions cements his legacy as a pioneering force in the world of inventions and innovations. His remarkable track record of success and his relentless pursuit of excellence continue to inspire and empower future generations of inventors and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…